Volunteer Botanicals, conducted a gene expression study to determine how the company’s plant-based Satival powders would affect expression levels of 10 human genes closely associated with pain, wound healing and inflammation. Directed by Vanderbilt University Medical Center-trained Dr. Jacob H. Basham, the study concluded that the Satival plant-based powders demonstrated a significant increase in activation within these key genes.
“This study shows without question that no longer is there just anecdotal reports of Satival powders generating a biological effect,” stated Derek Odette, chief executive officer at Volunteer Botanicals. “We now know that the cannabinoids, botanical and vitamin formulations using Satival powder initiates a measurable biological change in human genes.”
Conducted in June 2022, the study examined the changes in gene expression levels created in human cells when these cells were exposed to different Satival powders, formulated to aid with sleep, pain management or inflammation. The study was performed using the full thickness epilntestinal tissue model, a 3D reconstructed tissue model produced from normal, human-derived small intestinal epithelial cells, endothelial cells and fibroblasts. Each of the 10 genes studied are known to be utilized primarily by the immune system to regulate pain, inflammation and wound healing. Once exposed to the formulations, eight of the 10 genes observed had produced a statistically significant response within a 24-hour period.
Satival formulations bring reconstituted, powderized cannabinoids, botanicals and vitamins to market for use in a variety of ratio-specific wellness products. Volunteer Botanicals is currently developing a new line of wellness supplement products designed to take advantage of the unique capabilities of Satival to help provide relief from common conditions like insomnia, inflammation and pain.
“Further research needs to be conducted on the impacts of cannabinoids, but the results of this study show that plant-based supplements are headed in the right direction,” Odette continued.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo by Richard T on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.